CN111202827A - Chinese medicine for preventing influenza, SARS, bird flu and new coronary pneumonia - Google Patents
Chinese medicine for preventing influenza, SARS, bird flu and new coronary pneumonia Download PDFInfo
- Publication number
- CN111202827A CN111202827A CN202010220123.1A CN202010220123A CN111202827A CN 111202827 A CN111202827 A CN 111202827A CN 202010220123 A CN202010220123 A CN 202010220123A CN 111202827 A CN111202827 A CN 111202827A
- Authority
- CN
- China
- Prior art keywords
- sars
- influenza
- chinese medicine
- steps
- preventing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/238—Saposhnikovia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
- A61K36/575—Magnolia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9064—Amomum, e.g. round cardamom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine for preventing influenza, SARS, avian influenza and new coronary pneumonia, which comprises the following components: astragalus root, white atractylodes rhizome, ledebouriella root, areca nut, magnolia bark and amomum tsao-ko, a preparation method of a traditional Chinese medicine for preventing influenza, SARS, bird flu and new crown pneumonia, wherein the astragalus root, the white atractylodes rhizome, the ledebouriella root, the areca nut, the magnolia bark and the amomum tsao-ko are processed according to a conventional method to prepare corresponding traditional Chinese medicine preparations, and the traditional Chinese medicine preparations are powder, medicinal tea or granules; the powder is prepared by the following steps: weighing radix astragali, Atractylodis rhizoma, radix Saposhnikoviae, Arecae semen, cortex Magnolia officinalis and fructus Tsaoko in proportion, pulverizing into coarse powder, mixing, decocting with water to obtain decoction, and taking warm or soaking in boiling water, or making into granule. The invention combines the six medicines, can tonify qi, strengthen the exterior, improve the immunity of human bodies, expel pathogenic factors out of the bodies, has better prevention effect on patients not infected with viruses, and also has the effect of preventing and controlling the outbreak of recessive infected patients, latent patients and patients in early disease stage.
Description
Technical Field
The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to a traditional Chinese medicine for preventing influenza, SARS, avian influenza and neocoronary pneumonia.
Background
Influenza, SARS, avian influenza and new coronary pneumonia are acute infectious diseases caused by virus infection, and are mainly caused by respiratory symptoms such as fever, nasal obstruction, pharyngalgia and cough at the beginning, and are partially caused by digestive tract symptoms such as inappetence and diarrhea. Patients with severe symptoms can cause dyspnea and/or hypoxemia, and severe patients can progress to respiratory distress syndrome, septic shock, metabolic acidosis, blood coagulation dysfunction and multi-organ functional failure. Human beings generally lack immunity to virus infection, and when influenza, SARS, avian influenza and new coronary pneumonia are infected, wide outbreak can be caused in the crowd, which causes great damage to the life health of human beings and the production and economy of the society.
The traditional Chinese medicine is mainly classified into the category of pestilence for influenza, SARS, avian influenza and new coronary pneumonia, and a lot of prevention and treatment experiences are accumulated in the process of fighting with pestilence by applying the traditional Chinese medicine for thousands of years, so that Chinese people can multiply and grow vigorously. The "interior channel" has the discussion of "healthy qi stays in the interior, the pathogenic factors cannot be dried out" and "pathogenic factors are mixed together, the qi must be deficient", which embodies the dialectical thought of preventing and treating infectious diseases in traditional Chinese medicine. The jade screen powder developed by gold doctors is a traditional Chinese medicine prescription for preventing and treating infectious diseases developed by applying the classical theory. The formula consists of astragalus, bighead atractylodes rhizome and divaricate saposhnikovia root, prevents wind evil from attacking the exterior on the basis of tonifying qi, achieves the effects of tonifying qi and strengthening exterior, and is equivalent to adding a screen on the body surface of a human body, so that exogenous pathogens cannot directly invade the interior.
Wu Jia Wu in Ming Feng can indicate that the disease is warm epidemic, not wind, not cold, not summer-heat, not damp, and is a different sensation of qi between the heaven and earth. The key point of preventing and treating epidemic diseases is to eliminate the pathogenic factors 'miscellaneous qi' hidden in the body, so that a 'Dayuan drink' formula is created and comprises seven medicines of areca nut, mangnolia officinalis, tsaoko amomum fruit, rhizoma anemarrhenae, radix paeoniae alba, radix scutellariae and liquorice. Meanwhile, the other points out that the betel nut, the officinal magnolia bark and the tsaoko amomum fruit are main therapeutic drugs, and the following four auxiliary drugs are applied according to the symptoms. The formula has the effects of opening up the membrane source and removing dirt and turbid, is equivalent to adding a group of scavenger to the human body and expelling pathogenic factors invading the immune system and tissue cells of the human body.
The invention combines the main medicines of Yupingfeng powder and Dayunyuan drink into a new prescription on the basis of integrating the medical experience of preventing and treating epidemic diseases of ancestors of traditional Chinese medicine, and develops a Chinese herbal medicine for preventing diseases such as influenza, SARS, avian influenza, new coronary pneumonia and the like.
Disclosure of Invention
The present invention aims at providing one kind of Chinese medicine for preventing influenza, SARS, bird flu and new coronary pneumonia. The formula focuses on tonifying qi, strengthening the exterior and improving the immunity of the human body, and focuses on expelling pathogenic factors and preventing viruses from spreading in the body to cause diseases. The medicine has better prevention effect on people who are not infected with viruses; but also has better treatment effect on recessive infectors, latent patients and patients in early disease. Thereby achieving the purpose of preventing influenza, SARS, avian influenza, new coronary pneumonia and other virus infections.
In order to achieve the purpose, the invention adopts the technical scheme that: a Chinese medicine for preventing influenza, SARS, avian influenza and new coronary pneumonia comprises the following components: astragalus root, white atractylodes rhizome, ledebouriella root, areca nut, magnolia bark and amomum tsao-ko.
The technical scheme of further improvement in the technical scheme is as follows:
1. in the scheme, the ratio of the divaricate saposhnikovia root, the astragalus membranaceus, the bighead atractylodes rhizome, the betel nut, the mangnolia officinalis and the amomum tsao-ko is 2:2:4:4:2: 1.
2. In the scheme, the total amount of the divaricate saposhnikovia root, the astragalus, the largehead atractylodes rhizome, the areca seed, the officinal magnolia bark and the tsaoko amomum fruit is 20-50 g
The other technical scheme of the invention is as follows:
a Chinese medicinal preparation for preventing influenza, SARS, avian influenza and neocoronary pneumonia is prepared from radix astragali, Atractylodis rhizoma, radix Saposhnikoviae, Arecae semen, cortex Magnolia officinalis and fructus Tsaoko by processing according to conventional method, and making into corresponding Chinese medicinal preparation in the form of powder, medicated tea or granule.
The technical scheme of further improvement in the technical scheme is as follows:
1. in the above scheme, the powder is prepared by the following steps: weighing radix astragali, Atractylodis rhizoma, radix Saposhnikoviae, Arecae semen, cortex Magnolia officinalis and fructus Tsaoko in proportion, pulverizing into coarse powder, mixing, and making into powder.
2. In the scheme, the using method of the powder comprises the following steps: decocting with water for 15 min, and removing residue to obtain decoction which is warm for one week after noon.
3. In the scheme, the medicinal tea is prepared by the following steps: weighing radix astragali, Atractylodis rhizoma, radix Saposhnikoviae, Arecae semen, cortex Magnolia officinalis and fructus Tsaoko in proportion, pulverizing into coarse powder, mixing, and making into medicated tea.
4. In the scheme, the use method of the medicinal tea is to take one bag of medicinal tea every day, and the medicinal tea is brewed with boiling water and taken continuously for one week.
5. In the above scheme, the granules are prepared by the following steps: weighing radix astragali, Atractylodis rhizoma, radix Saposhnikoviae, Arecae semen, cortex Magnolia officinalis and fructus Tsaoko in proportion, refining by extraction, concentration, low temperature drying, etc. to obtain granule, and packaging in small bags in proportion.
6. In the scheme, the use method of the granules comprises the steps of taking a small bag of granules every day, dissolving the granules with boiled water, and taking the granules warm in the afternoon for one week continuously.
The technical scheme of the invention is further explained by combining the components of the formula:
yupingda original drink is based on prevention and combines prevention and treatment. The jade screen powder is used as a first defense line, and is matched with Dayunyuan beverage to achieve membrane origin to avoid filth and remove turbidity, and the jade screen powder is used as a second defense line, has a better prevention effect on patients who are not infected with viruses, and also has a better prevention and control effect on recessive infected patients, patients in a latent period and patients in an early disease stage. The formula takes qi-tonifying aromatic drugs as main drugs, does not use honeysuckle, fructus forsythiae, scutellaria baicalensis, coptis chinensis and other therapeutic drugs, prevents the defects of damaging yang by bitter cold and damaging yin by bitter dryness, and avoids the side effect and adverse reaction of the drugs on human bodies. The dosage of the formula is small, and the decoction is convenient to take. The waste of traditional Chinese medicine resources is reduced, the medicine price is low, and the development of large-group prevention work is facilitated.
In the process of preventing influenza, SARS, avian influenza and new coronary pneumonia by using the Yupingda original powder for 10 years, the Yupingda original powder is researched by combining the classical theory of traditional Chinese medicine and the pharmacology of related traditional Chinese medicines, and the medicine of the Yupingda original powder is found to have the pharmacologic actions of generally inhibiting bacteria, resisting inflammation and viruses and improving the immunologic function. Such as wherein: the wind-proof decoction and the compound thereof have the function of inhibiting influenza virus A3. The radix sileris crude extract has the function of resisting Columbia SK virus and also has the functions of bacteriostasis, anti-inflammation and immunity improvement. The astragalus root has the antiviral effect, can improve the capacity of white cells to induce interferon by viruses, and has the bidirectional regulation effect on the immune function of a human body. The water extract of the white atractylodes rhizome also has obvious functions of bacteriostasis, anti-inflammation and regulating the immune function, and the lactone III of the white atractylodes rhizome has the function of inactivating rotavirus. Arecae semen has effects in inhibiting helicobacter pylori, Trichophyton schoenleinii, influenza virus, and expelling parasites. The fructus Tsaoko also has antibacterial and antifungal effects. Magnolol, etc. contained in cortex Magnolia officinalis have antiviral effect, and cortex Magnolia officinalis decoction has broad-spectrum antibacterial and antiallergic effects.
Due to the application of the technical scheme, compared with the prior art, the invention has the following advantages:
1. the invention relates to a Chinese medicament for preventing influenza, SARS, avian influenza and new coronary pneumonia, which combines six medicaments, supplements qi and strengthens the exterior, can expel pathogenic factors, avoid filth and remove turbidity, improve the immunity of human bodies, has better prevention effect on patients who are not infected with viruses, also has better treatment effect on recessive infected patients, latent patients and patients in early disease stage, and achieves the purpose of preventing viral infections such as influenza, SARS, avian influenza, new coronary pneumonia and the like.
2. The invention relates to a traditional Chinese medicine for preventing influenza, SARS, avian influenza and new coronary pneumonia, which takes qi-tonifying aromatic medicine as main medicine, does not use honeysuckle, forsythia, scutellaria, coptis and other therapeutic medicines, prevents the defects of bitter cold damaging yang and bitter dryness damaging yin, avoids the side effect and adverse reaction of the medicine to human body, has small dosage, is convenient to decoct, reduces the waste of traditional Chinese medicine resources, has low medicine price, and is beneficial to the development of large-group prevention work.
Detailed Description
The invention is further described below with reference to the following examples:
example 1: a Chinese medicine for preventing influenza, SARS, avian influenza and new coronary pneumonia is characterized in that: comprises the following components: astragalus root, white atractylodes rhizome, ledebouriella root, areca nut, magnolia bark and tsaoko cardamom, wherein the ledebouriella root is 3 g, astragalus root is 3 g, white atractylodes rhizome is 6 g, areca nut is 6 g, magnolia bark is 3 g and tsaoko cardamom is 1.5 g.
A Chinese medicinal composition for preventing influenza, SARS, avian influenza and neocoronary pneumonia is prepared by weighing radix astragali, Atractylodis rhizoma, radix Saposhnikoviae, Arecae semen, cortex Magnolia officinalis and fructus Tsaoko at a certain proportion, pulverizing into coarse powder, mixing, and making into powder.
The using method of the powder comprises the following steps: decocting with water for 15 min, and removing residue to obtain decoction which is warm for one week after noon.
Example 2: a Chinese medicine for preventing influenza, SARS, avian influenza and new coronary pneumonia is characterized in that: comprises the following components: astragalus root, white atractylodes rhizome, ledebouriella root, areca nut, magnolia bark and tsaoko cardamom, wherein the ledebouriella root is 6 g, astragalus root is 6 g, white atractylodes rhizome is 12 g, areca nut is 12 g, magnolia bark is 6 g and tsaoko cardamom is 3 g.
A preparation method of a traditional Chinese medicine for preventing influenza, SARS, avian influenza and new coronary pneumonia comprises the following steps: weighing radix astragali, Atractylodis rhizoma, radix Saposhnikoviae, Arecae semen, cortex Magnolia officinalis and fructus Tsaoko in proportion, pulverizing into coarse powder, mixing, and making into medicated tea.
The application method of the medicinal tea comprises taking one bag of medicinal tea every day, and infusing with boiling water for drinking continuously for one week.
Example 3: a Chinese medicine for preventing influenza, SARS, avian influenza and new coronary pneumonia is characterized in that: comprises the following components: astragalus root, white atractylodes rhizome, ledebouriella root, areca nut, magnolia bark and tsaoko cardamom, wherein the ledebouriella root is 4.5 g, astragalus root is 4.5 g, white atractylodes rhizome is 9 g, areca nut is 9 g, magnolia bark is 4.5 g and tsaoko cardamom is 2.25 g.
A preparation method of a traditional Chinese medicine for preventing influenza, SARS, avian influenza and neocoronary pneumonia comprises the following steps: the preparation method comprises the steps of weighing astragalus mongholicus, bighead atractylodes rhizome, divaricate saposhnikovia root, betel nut, mangnolia officinalis and amomum tsao-ko according to a proportion, refining into granules by adopting processes of extraction, concentration, low-temperature drying and the like, and subpackaging the granules into small bags for later use by taking raw materials of 4.5 g of divaricate saposhnikovia root, 4.5 g of astragalus mongholicus, 9 g of bighead atractylodes rhizome, 9 g of betel nut, 4..
The application method of the granule comprises dissolving a small bag of the granule with boiling water every day, and taking the granule warm in the afternoon for one week.
Clinical experiments were performed using the traditional Chinese medicine preparation prepared in example 1:
5000 people who adopt the invention to track and prevent the new coronary pneumonia age 25-70 years old; 30 suspected cases are aged 25-70 years.
The medication method comprises the following steps: it is administered daily in the afternoon for one week.
As a result: 5000 patients with no symptoms show no infection signs within one month after taking the medicine; the suspected case has no symptom after taking the medicine and is recovered to be healthy.
The above-mentioned aspects of the invention are further explained as follows:
the invention starts from 2003SARS epidemic period, as western medicine has no effective preventive medicine and no specific medicine for resisting virus, the invention has the advantages of immediate spread and rapid spread, fierce disease, relatives and friends and patients in medical treatment hope that the Chinese medicine formula can be developed for preventing and controlling epidemic diseases, the invention combines the main medicines of the famous Chinese medicine epidemic prevention formula of Yupingfengsan and Dayunyuan drink into one party on the basis of inheriting the medical treatment experience of the elders of Chinese medicine for preventing and treating the epidemic diseases, the named Yupingyangduan san is applied at the clinical treatment, and the invention discovers that the SARS does not cause infection and the common cold does not cause infection at ordinary times. Since 2004, avian influenza has also been outbreak at home and abroad, and the disease is also caused by virus, i also took the Yupingyan Dayuan to the public with the same effect. In the outbreak process of the new coronary pneumonia, the traditional Chinese and western medicine combined hospital in Suzhou city prepares a large amount of medicaments, on one hand, the patients with the new coronary pneumonia are matched with the medicaments by fever outpatient physicians and other clinicians, on the other hand, the medicaments are taken by 5000 people at the front of epidemic prevention medical care personnel and cadres at the front of the department such as the gold hospital in Wu Zhongzhong, the government in Wu Zhongzhong, the health care committee in Wu Zhongzhong and the like, and all the personnel do not find the new coronary pneumonia and other respiratory infectious diseases infected by the.
The above embodiments are merely illustrative of the technical ideas and features of the present invention, and the purpose thereof is to enable those skilled in the art to understand the contents of the present invention and implement the present invention, and not to limit the protection scope of the present invention. All equivalent changes and modifications made according to the spirit of the present invention should be covered within the protection scope of the present invention.
Claims (10)
1. A Chinese medicine for preventing influenza, SARS, avian influenza and new coronary pneumonia is characterized in that: comprises the following components: astragalus root, white atractylodes rhizome, ledebouriella root, areca nut, magnolia bark and amomum tsao-ko.
2. The traditional Chinese medicine for preventing influenza, SARS, avian influenza and neocoronary pneumonia according to claim 1, characterized in that: the proportion of the divaricate saposhnikovia root, the astragalus root, the largehead atractylodes rhizome, the betel nut, the officinal magnolia bark and the tsaoko amomum fruit is 2:2:4:4:2: 1.
3. The traditional Chinese medicine for preventing influenza, SARS, avian influenza and neocoronary pneumonia according to claim 1, characterized in that: the total amount of the divaricate saposhnikovia root, the astragalus root, the largehead atractylodes rhizome, the betel nut, the officinal magnolia bark and the tsaoko amomum fruit is 20-50 g.
4. The preparation method of the traditional Chinese medicine for preventing influenza, SARS, avian influenza and neocoronary pneumonia according to claim 1, characterized in that: processing radix astragali, rhizoma Atractylodis Macrocephalae, radix Saposhnikoviae, semen Arecae, cortex Magnoliae officinalis and fructus Tsaoko by conventional method to obtain corresponding Chinese medicinal preparation in the form of powder, medicated tea or granule.
5. The method for preparing a Chinese medicinal composition for preventing influenza, SARS, avian influenza and neocoronary pneumonia according to claim 4, wherein the preparation method comprises the steps of: the powder is prepared by the following steps: weighing radix astragali, Atractylodis rhizoma, radix Saposhnikoviae, Arecae semen, cortex Magnolia officinalis and fructus Tsaoko in proportion, pulverizing into coarse powder, mixing, and making into powder.
6. The method for preparing a Chinese medicinal composition for preventing influenza, SARS, avian influenza and neocoronary pneumonia according to claim 5, wherein the preparation method comprises the steps of: the using method of the powder comprises the following steps: decocting with water for 15 min, and removing residue to obtain decoction which is warm for one week after noon.
7. The method for preparing a Chinese medicinal composition for preventing influenza, SARS, avian influenza and neocoronary pneumonia according to claim 4, wherein the preparation method comprises the steps of: the medicinal tea is prepared by the following steps: weighing radix astragali, Atractylodis rhizoma, radix Saposhnikoviae, Arecae semen, cortex Magnolia officinalis and fructus Tsaoko in proportion, pulverizing into coarse powder, mixing, and making into medicated tea.
8. The method for preparing a Chinese medicinal composition for preventing influenza, SARS, avian influenza and neocoronary pneumonia according to claim 7, wherein the preparation method comprises the steps of: the application method of the medicinal tea comprises taking one bag of medicinal tea every day, and infusing with boiling water for drinking continuously for one week.
9. The method for preparing a Chinese medicinal composition for preventing influenza, SARS, avian influenza and neocoronary pneumonia according to claim 4, wherein the preparation method comprises the steps of: the granules are prepared by the following steps: weighing radix astragali, Atractylodis rhizoma, radix Saposhnikoviae, Arecae semen, cortex Magnolia officinalis and fructus Tsaoko in proportion, refining by extraction, concentration, low temperature drying, etc. to obtain granule, and packaging in small bags in proportion.
10. The method for preparing a Chinese medicine for preventing influenza, SARS, avian influenza and neocoronary pneumonia according to claim 9, wherein the method comprises the following steps: the application method of the granule comprises dissolving a small bag of the granule with boiling water every day, and taking the granule warm in the afternoon for one week.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010220123.1A CN111202827A (en) | 2020-03-25 | 2020-03-25 | Chinese medicine for preventing influenza, SARS, bird flu and new coronary pneumonia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010220123.1A CN111202827A (en) | 2020-03-25 | 2020-03-25 | Chinese medicine for preventing influenza, SARS, bird flu and new coronary pneumonia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111202827A true CN111202827A (en) | 2020-05-29 |
Family
ID=70782018
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010220123.1A Pending CN111202827A (en) | 2020-03-25 | 2020-03-25 | Chinese medicine for preventing influenza, SARS, bird flu and new coronary pneumonia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111202827A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112494534A (en) * | 2020-10-09 | 2021-03-16 | 吴伟忠 | Traditional Chinese medicine composition for complications of new coronary pneumonia and preparation method thereof |
| CN115486488A (en) * | 2022-06-16 | 2022-12-20 | 南方医科大学深圳医院 | Tea drink composition for common food and application thereof |
| CN115486487A (en) * | 2022-06-16 | 2022-12-20 | 南方医科大学深圳医院 | Tea drink composition based on medicinal and edible traditional Chinese medicinal materials and application thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1088822A (en) * | 1992-12-31 | 1994-07-06 | 山东北方制药厂 | Anti-Chinese medicine that cures cold and preparation method thereof |
-
2020
- 2020-03-25 CN CN202010220123.1A patent/CN111202827A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1088822A (en) * | 1992-12-31 | 1994-07-06 | 山东北方制药厂 | Anti-Chinese medicine that cures cold and preparation method thereof |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112494534A (en) * | 2020-10-09 | 2021-03-16 | 吴伟忠 | Traditional Chinese medicine composition for complications of new coronary pneumonia and preparation method thereof |
| CN115486488A (en) * | 2022-06-16 | 2022-12-20 | 南方医科大学深圳医院 | Tea drink composition for common food and application thereof |
| CN115486487A (en) * | 2022-06-16 | 2022-12-20 | 南方医科大学深圳医院 | Tea drink composition based on medicinal and edible traditional Chinese medicinal materials and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101095736B (en) | Chinese traditional medicine composition for treating acute and chronic pharyngitis, tonsillitis and method of making the same | |
| CN111202827A (en) | Chinese medicine for preventing influenza, SARS, bird flu and new coronary pneumonia | |
| WO2021179505A1 (en) | Forsythia suspensa and astragalus membranaceus compound preparation, preparation method therefor and application thereof | |
| CN101284064A (en) | Preparation method of kudzuvine root and indigowoad root tablets for reducing fat and alleviating hangover | |
| CN103386022B (en) | Chinese medicine composition for treating tuberculous pleurisy | |
| CN101411782A (en) | Pharmaceutical composition for treating acute pharyngitis and preparation method thereof | |
| CN101297889A (en) | Chinese medicine preparation for treating foot-and-mouth disease and preparation method thereof | |
| CN113813347A (en) | Preparation method and process of compound paclitaxel anti-tumor capsule tablet | |
| CN103656410A (en) | Traditional Chinese medicine preparation for treating cough and preparation method thereof | |
| CN111714553A (en) | A Chinese medicinal composition for treating new coronary pneumonia and/or influenza, and its preparation method | |
| CN101181383A (en) | Medicine composition for treating apoplexy as well as preparation method | |
| CN101138613A (en) | Traditional Chinese medicine for treating acute bronchitis of children | |
| CN107890528B (en) | Traditional Chinese medicine composition for treating hyperuricemia and preparation method thereof | |
| CN105943963A (en) | Medicine for treating pig pneumonia | |
| CN101164587A (en) | Traditional Chinese medicine for treating palpitation restlessness, chest distress and short breath | |
| CN101199788B (en) | Medicament for treating asthma | |
| CN1399999A (en) | Medicine for curing malignant turnor and its preparation method | |
| CN105641419A (en) | Traditional Chinese medicine composition for treating Yin deficiency type cough caused by lung cancer | |
| CN102048930A (en) | Formula of traditional Chinese medicine for treating chronic gastritis | |
| CN101549140B (en) | Traditional Chinese medicine composition for treating AIDS and preparation method thereof | |
| CN105797092B (en) | Yiyuan anti-cold mixture | |
| CN109316551A (en) | A kind of Chinese medicine composition and preparation method thereof for treating acpuei pharyngitis | |
| CN102805795B (en) | Chinese medicinal composition for treating acute soft tissue injury of chest and hypochondrium and application thereof | |
| CN108159257A (en) | Treat Chinese medicine composition of chronic enteritis and preparation method thereof | |
| CN101884762B (en) | Traditional Chinese medicine for treating emphysema |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200529 |